{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2016", "item": "https://www.patentleaderboard.com/2016/"}, {"@type": "ListItem", "position": 3, "name": "Array Biopharma", "item": "https://www.patentleaderboard.com/2016/company/array-biopharma"}, {"@type": "ListItem", "position": 4, "name": "Rui Xu", "item": "https://www.patentleaderboard.com/2016/inventor/fl:ru_ln:xu-35"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
RX

Rui Xu — 5 Patents in 2016

ABArray Biopharma: 5 patents #2 of 92Top 3%
Genentech: 3 patents #16 of 349Top 5%
Overall (2016): #24,227 of 481,213Top 6%
5 Patents 2016

Issued Patents 2016

Showing 1–5 of 5 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
9409886 Pyrimidyl cyclopentanes as AKT protein kinase inhibitors Josef R. Bencsik, James F. Blake, James Graham, Martin F. Hentemann, Nicholas C. Kallan +7 more 2016-08-09 $6,696,000
9359340 Hydroxylated and methoxylated pyrimidyl cyclopentanes as Akt protein kinase inhibitors Ian S. Mitchell, James F. Blake, Nicholas C. Kallan, Dengming Xiao, Keith L. Spencer +9 more 2016-06-07 $6,197,000
9346805 Pyrimidyl cyclopentanes as Akt protein kinase inhibitors Anna L. Banka, Josef R. Bencsik, James F. Blake, Kin Chiu Fong, Martin F. Hentemann +5 more 2016-05-24 $5,944,000
9328091 5H-cyclopenta[d]pyrimidines as AKT protein kinase inhibitors Anna L. Leivers, Josef R. Bencsik, James F. Blake, Martin F. Hentemann, Nicholas C. Kallan +5 more 2016-05-03
9303040 Substituted piperazines as AKT inhibitors Ian S. Mitchell, James F. Blake, Nicholas C. Kallan, Dengming Xiao, Keith L. Spencer +1 more 2016-04-05 $5,397,000